- ASLAN Pharmaceuticals (NASDAQ:ASLN) Monday filed a prospectus related to the proposed resale of about 5M ADS, representing about 125M shares, by selling stockholders.
- This prospectus is not an offer to sell these securities.
- SEC Filing
ASLAN Pharmaceuticals files to sell 125M shares for holders
Recommended For You
More Trending News
About ASLN Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| ASLN | - | - |
| ASLAN Pharmaceuticals Limited | ||